SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G. Kaelin Jr., Jose Baselga, and Antoni Ribas in 2017 and is headquartered in Boston, MA.

Tango Therapeutics Inc

Tango Therapeutics is generating significant buzz due to promising Phase 1/2 clinical data for its TNG462 cancer therapy in MTAP-deleted cancers, alongside a substantial $225 million PIPE financing. The community is actively discussing the potential "best-in-class" status of its oncology pipeline, with some analysts raising price targets and speculation growing around future growth or acquisition, despite recent price fluctuations.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals (VNDA) is trending following the FDA's approval of BYSANTI (milsaperidone) for Bipolar I Disorder and Schizophrenia, with market participants eagerly anticipating a significant re-rating of its valuation. The drug's New Chemical Entity (NCE) status and patent protection through 2044, combined with the potential of its GLP-1 nausea candidate, are fueling widespread community discussion about a possible near-term buyout.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as community optimism grows around QNX's deepening integration into next-generation software-defined vehicles with key design wins like BMW's Neue Klasse and partnerships such as Alloy Kore with Vector, leading to expectations of accelerated revenue growth and strong Q3 earnings from its expanding automotive software portfolio.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after reporting overwhelmingly positive Phase 2 trial results for sonelokimab in axSpA, with the community celebrating its "disease-modifying" potential and best-in-class efficacy, leading to widespread speculation about a significant re-rating, potential buyout, and high anticipation for its upcoming investor day.

Synthetix is a decentralized perpetual futures protocol built on Ethereum Mainnet. Synthetix uses a hybrid design — off-chain order matching on a high-performance CLOB with on-chain settlement — to deliver low latency, deep liquidity, and MEV-resistant execution while keeping custody and finality on Ethereum. Traders get CEX-like performance with on-chain security and composability. The protocol’s liquidity is provided by the Synthetix Liquidity Provider (SLP) vault and backstopped by staked SNX collateral, which underwrites the issuance of the sUSD stablecoin and the solvency of the SLP vault.

Synthetix Network 

Synthetix Network is trending due to the launch of its V3 perpetuals on Ethereum Mainnet, alongside a widely discussed $1 million trading competition and a strategic shift to a deflationary token model with upcoming buybacks. The community is buzzing with both bullish excitement for this return to L1 derivatives infrastructure and caution regarding market volatility.

Warner Music Group Corp. engages in the publishing and recording of music. It operates through the Recorded Music and Music Publishing segments. The Recorded Music segment is involved in the sale, marketing, distribution, and licensing of recorded music produced by the company's recording artists. The Music Publishing segment acts as a copyright owner and/or administrator of the musical compositions and generates revenues related to the exploitation of musical compositions. The company was founded on November 21, 2003 and is headquartered in New York, NY.

Warner Music Group Corp - Ordinary Shares - Class A

Warner Music Group is trending due to its new multi-year partnership with Spotify, focused on expanding fan experiences and monetization, alongside its inclusion in the S&P MidCap 400. The community is actively discussing these growth catalysts and recent analyst upgrades, though some express caution regarding artist cost pressures and existing leverage.

Insight Enterprises, Inc. engages in the provision of information technology (IT) hardware, software, and services. The firm offers supply chain optimization, connected workforce, cloud and data center transformation, and digital innovation. It operates through the following geographical segments: North America, Europe, Middle East, and Africa (EMEA), and Asia-Pacific (APAC). The company was founded by Eric J. Crown and Timothy A. Crown in 1988 and is headquartered in Chandler, AZ.

Insight Enterprises Inc.

Insight Enterprises is trending following its Q4 earnings recap, which revealed strong GAAP EPS growth and a positive outlook, complemented by strategic moves like a new AWS collaboration and the Sekuro cybersecurity acquisition. The community remains divided, discussing the company's strong positioning in digital transformation and cloud against some revenue misses, fueling active debate and technical plays including short squeeze speculation.

Sprott Funds Trust. - Sprott Copper Miners ETF

$COPP is gaining significant attention as copper prices reach record highs, primarily driven by discussions around potential import tariffs and increasing demand for AI infrastructure and global electrification. The community is actively debating the prospects of a copper supercycle amid ongoing supply challenges.

Autodesk, Inc. engages in the design of software and services. Its products include AutoCAD, BIM Collaborate Pro, Revit, Civil 3D, Fusion 360, InfraWorks, Inventor, Maya, PlanGrid, Revit, Shotgun, and 3ds Max. The firm also offers product development and manufacturing software, which provides manufacturers in the automotive, transportation, industrial machinery, consumer products, and building product industries with digital design, engineering, and production solutions. The firm is also involved in digital media and entertainment, which consists of tools for digital sculpting, modeling, animation, effects, rendering, and compositing for design visualization, visual effects, and games production. The company was founded by John Walker in April 1982 and is headquartered in San Francisco, CA.

Autodesk Inc.

Autodesk is trending as activist investor Starboard Value has taken a significant stake, pushing for board and management changes while suing to delay the annual meeting, which is fueling community debate over the company's accounting practices and its strategy for AI-driven growth in the design software sector.

Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.

Krystal Biotech Inc

Krystal Biotech is gaining traction following solid Vyjuvek sales and encouraging pipeline updates for gene therapies in cystic fibrosis and ocular conditions, fueling community optimism about its commercial execution and potential as a buyout target within the consolidating biotech sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Buying: Senestech (NASDAQ:SNES) Major Shareholder Buys 34,613 Shares of Stock

Senestech, Inc. (NASDAQ:SNES - Get Free Report) major shareholder Glenbrook Capital Management acquired 34,613 shares of the stock in a transaction dated Thursday, February 19th. The shares were...

SenesTech Reports Significant Reductions in Rodent Activity Following Evolve Deployments in Urban Field Studies

SenesTech Reports Significant Reductions in Rodent Activity Following Evolve Deployments in Urban Field Studies SenesTech Reports Significant Reductions in Rodent Activity Following Evolve...

Senestech (NASDAQ:SNES) Major Shareholder Glenbrook Capital Management Acquires 7,956 Shares

Senestech, Inc. (NASDAQ:SNES - Get Free Report) major shareholder Glenbrook Capital Management bought 7,956 shares of the firm's stock in a transaction that occurred on Thursday, February 12th. The...

Senestech (NASDAQ:SNES) Major Shareholder Glenbrook Capital Management Buys 5,685 Shares

Senestech, Inc. (NASDAQ:SNES - Get Free Report) major shareholder Glenbrook Capital Management bought 5,685 shares of Senestech stock in a transaction dated Wednesday, February 4th. The stock was...

SenesTech Announces CEO Transition Plan

SenesTech Announces CEO Transition Plan SenesTech Announces CEO Transition Plan PR Newswire PHOENIX, Jan. 28, 2026 Board To Initiate Search For New Leadership As Current CEO Plans RetirementDr. Jamie...

SenesTech Expands International Reach with the Addition of the Belize Raptor Center as an Official Distributor of Evolve Rat Birth Control

SenesTech Expands International Reach with the Addition of the Belize Raptor Center as an Official Distributor of Evolve Rat Birth Control SenesTech Expands International Reach with the Addition of...

SenesTech Reports Third Quarter 2025 Financial Results with Record Revenue and Adjusted EBITDA

SenesTech Reports Third Quarter 2025 Financial Results with Record Revenue and Adjusted EBITDA SenesTech Reports Third Quarter 2025 Financial Results with Record Revenue and Adjusted EBITDA PR...

SenesTech's Evolve Rat Birth Control Now Available Online at Lowes.com

SenesTech's Evolve Rat Birth Control Now Available Online at Lowes.com SenesTech's Evolve Rat Birth Control Now Available Online at Lowes.com PR Newswire SURPRISE, Ariz., Nov. 10, 2025 E-Commerce...

Uncovering Potential: SenesTech's Earnings Preview

Celanese (CE) Beats Q3 Earnings Estimates

Celanese (CE) delivered earnings and revenue surprises of +5.51% and -1.69%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations. The firm focuses on rat populations through fertility control. It offers its ContraPest product to residential and commercial sectors such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer on July 27, 2004 and is headquartered in Phoenix, AZ.

SNES
SenesTech Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SNES News

SNESSenesTech Inc